Misonix Buys ProRhythm IP

Misonix Inc. (Nasdaq: MSON) has acquired three patents associated with high intensity focused ultrasound from ProRhythm Inc. No financial terms were disclosed. ProRhythm shareholders include L Capital Partners and St. Jude Medical Inc.

14 June 2009•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail